Abstract Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory disorders of the digestive tract resulting from dysregulated immune responses toward environmental factors in genetically predisposed individuals. This review focus on what is the state of the art of UC pathophysiology, diagnosis, and treatment and how any future findings could drive our clinical practice.
Lopetuso, L. R., Gasbarrini, A., [Ulcerative colitis], <<RECENTI PROGRESSI IN MEDICINA>>, 2016; 107 (6): 297-308-N/A. [doi:10.1701/2296.24690] [http://hdl.handle.net/10807/93888]
Autori: | ||
Titolo: | [Ulcerative colitis] | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1701/2296.24690 | |
Data di pubblicazione: | 2016 | |
Abstract: | Abstract Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory disorders of the digestive tract resulting from dysregulated immune responses toward environmental factors in genetically predisposed individuals. This review focus on what is the state of the art of UC pathophysiology, diagnosis, and treatment and how any future findings could drive our clinical practice. | |
Lingua: | Italiano | |
Rivista: | ||
Citazione: | Lopetuso, L. R., Gasbarrini, A., [Ulcerative colitis], <<RECENTI PROGRESSI IN MEDICINA>>, 2016; 107 (6): 297-308-N/A. [doi:10.1701/2296.24690] [http://hdl.handle.net/10807/93888] | |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |